Citra Nusantara Gemilang Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp153 (market cap 272.81B, 2.21M 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B, 600 24h volume). The key difference: Citra Nusantara Gemilang Tbk. and Ikapharmindo Putramas Tbk. are close in size by market cap, and Citra Nusantara Gemilang Tbk. is more actively traded (2.21M versus 600). Which is the better fit depends on your goals.
| CGAS | IKPM | |
|---|---|---|
Market Cap | 272.81B | 308.29B |
Volume | 2.21M | 600 |
Lot | 22.11K | 6 |
Turnover | 337.89M | 109.5K |
Average Price | 152.83 | 182.5 |
Value | 337.89M | 109.5K |
Indicative Equilibrium Price | 154 | 183 |
Indicative Equilibrium Volume | 94.2K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →